ACOG section

Obstetrics and Gynecology

Volumn 98, Issue 1, 2001, Pages 177-192

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIURETIC AGENT; ENALAPRIL; LABETALOL; LISINOPRIL; METHYLDOPA; NIFEDIPINE;

BORDERLINE HYPERTENSION; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG EFFECT; FETUS MORTALITY; HUMAN; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; LABORATORY TEST; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MATERNAL WELFARE; NEWBORN MORTALITY; NOMENCLATURE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOLUTIO PLACENTAE;

EID: 0034929239     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(01)01471-5     Document Type: Review

References (52)

1. Chronic hypertension in pregnancy
2. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy
3. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy
4. Management of mild chronic hypertension during pregnancy: A review
5. Hypertension in pregnancy: Diagnosis and treatment
6. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy
7. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
8. Perinatal morbidity in chronic hypertension
9. Pregnancy out-come in 211 patients with mild chronic hypertension
10. Pregnancy outcome of intensive therapy in severe hypertension in first trimester
11. The prognosis of pregnancy in women with chronic hypertension
12. Hypertensive disorders of pregnancy and stillbirth in North Carolina, 1988 to 1991
13. Effect of pregnancy-induced and chronic hypertension on pregnancy outcome
14. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension
15. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: A meta-analysis of observational studies
16. Management of chronic hypertension during pregnancy
17. Chronic renal disease and pregnancy out-come
18. Pregnancy complicated by chronic renal disease
19. Peripartum heart failure: Idiopathic cardiomyopathy or compounding cardiovascular events?
20. Pulmonary edema associated with pregnancy: Echocardiographic insights and implications for treatment
21. Pheochromocytoma in pregnancy: Case report and review of the literature
22. Cushing syndrome in pregnancy
23. Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension
24. Prevalence of renal artery stenosis in type 2 diabetes
25. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy
26. Pregnancy in women with kidney disease
27. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy
28. Two-hour urine collection for evaluating renal function correlates with 24-hour urine collection in pregnant patients
29. Random protein-creatinine ratio for the quantitation of proteinuria in pregnancy
30. Urinary protein/creatinine ratio in hyperten-sive pregnant women
31. The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy
32. Endocrine disorders
33. Treatment of hypertension in pregnant women
34. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy
35. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: A meta-analysis
36. Fortnightly review: Management of hypertension in pregnancy
37. Maternal hypertension with superimposed pre-eclampsia: Effects on child development at 7 1/2 years
38. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hyperten-sion
39. Risks and benefits of beta-receptor blockers for pregnancy hypertension: Overview of the randomized trials
40. Effects of diuretics on plasma volume in pregnancies with long-term hypertension
41. Overview of randomized trials of diuretics in pregnancy
42. ACE inhibitor fetopathy and hypocalvaria: The kidney-skull connection
43. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy
44. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development
45. Angiotensin-converting enzyme inhibitor fetopathy
46. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy - United States, Canada, and Israel, 1987-1995
47. Angiotensin converting enzyme inhibitors use in the first trimester of pregnancy
48. Management of pre-eclampsia remote from term
49. Practice guidelines for obstetrical anesthesia: A report by the American Society of Anesthesiologists Task Force on Obstetrical Anesthesia
50. Safety of labor epidural anesthesia for women with severe hypertensive disease
51. Pregnancy-induced hypertension